RatyR., KleemolaM., MelenK.. Efficacy of PCR and other diagnostic methods for the detection of respiratory adenoviral infections.J Med Virol.1999; 59: 66–72.
LecatsasG., vanWykJ.A.. DNA viruses in urine after renal transplantation.S Afr Med J.1978; 53: 787–788.
12.
BrummittC.F., CherringtonJ.M., KatzensteinD.A.. Nosocomial adenovirus infections: molecular epidemiology of an outbreak due to adenovirus 3a.J Infect Dis.1988; 158: 423–432.
13.
FlomenbergP.R., ChenM., MunkG.. Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts.J Infect Dis.1987; 155: 1127–1134.
14.
KoneruB., AtchisonR., JaffeR.. Serological studies of adenoviral hepatitis following pediatric liver transplantation.Transplant Proc.1990; 22: 1547–1548.
15.
VarkiN.M., BhutaS., DrakeT.. Adenovirus hepatitis in two successive liver transplants in a child.Arch Pathol Lab Med.1990; 114: 106–109.
16.
KitabayashiA., HirokawaM., KurokiJ.. Successful vidarabine therapy for adenovirus type 11-associated acute hemorrhagic cystitis after allogeneic bone marrow transplantation.Bone Marrow Transplant.1994; 14: 853–854.
17.
CarmichaelGPJr, ZahradnikJ.M., MoyerG.H.. Adenovirus hepatitis in an immunosuppressed adult patient.Am J Clin Pathol.1979; 71: 352–355.
18.
BertheauP., ParquetN., FerchalF.. Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation.Bone Marrow Transplant.1996; 17: 295–298.
JohnsonP.R., YinJ.A., MorrisD.J.. Fulminant hepatic necrosis caused by adenovirus type 5 following bone marrow transplantation.Bone Marrow Transplant.1990; 5: 345–347.
21.
PurtiloD.T., WhiteR., FilipovichA.. Fulminant liver failure induced by adenovirus after bone marrow transplantation.N Engl J Med.1985; 312: 1707–1708.
22.
CharlesA.K., CaulE.O., PorterH.J.. Fatal adenovirus 32 infection in a bone marrow transplant recipient.J Clin Pathol.1995; 48: 779–781
23.
LjungmanP., EhrnstA., BjorkstrandB.. Lethal disseminated adenovirus type 1 infection in a patient with chronic lymphocytic leukemia.Scand J Infect Dis.1990; 22: 601–605.
24.
KrilovL.R., RubinL.G., FrogelM.. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states.Rev Infect Dis.1990; 12: 303–307.
25.
DombrowskiF., Eis-HubingerA.M., AckermannT.. Adenovirus-induced liver necrosis in a case of AIDS.Virchows Arch.1997; 431: 469–472.
26.
SaadR.S., DemetrisA.J., LeeR.G.. Adenovirus hepatitis in the adult allograft liver.Transplantation.1997; 64: 1483–1485.
NorrisS.H., ButlerT.C., GlassN.. Fatal hepatic necrosis caused by disseminated type 5 adenovirus infection in a renal transplant recipient.Am J Nephrol.1989; 9: 101–105.
29.
RodriguezFHJr, LiuzzaG.E., GohdR.H.. Disseminated adenovirus serotype 31 infection in an immunocompromised host.Am J Clin Pathol.1984; 82: 615–618.
30.
SouthM.A., DolenJ., BeachD.K.. Fatal adenovirus hepatic necrosis in severe combined immune deficiency.Pediatr Infect Dis.1982; 1: 416–419.
31.
Benyesh-MelnickM., RosenbergH.S.. The isolation of adenovirus type 7 from a fatal case of pneumonia and disseminated disease.J Pediatr.1964; 64: 83–87.
32.
AtermanK., EmbilJ., EasterbrookK.B.. Liver necrosis, adenovirus type 2 and thymic dysplasia.Virchows Arch.1973; 360: 155–171.
33.
WiggerH.J., BlancW.A.. Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia.N Engl J Med.1966; 275: 870–874.
34.
PereiraH.G., AllisonA.C., NivenJ.S.F.. Fatal infection of new-born hamsters by and adenovirus of human origin.Nature.1962; 196: 244–245.
35.
PostlethwaiteR.. Liver damage induced in mice by human adenovirus type 5.Scott Med J.1973; 18: 131.
36.
ShawR.K., SzwedC., BoggsD.R.. Infection and immunity in chronic lymphocytic leukemia.Arch Intern Med.1960; 106: 467–477.
UltmannJ.E., FishW., OssermanE.. The clinical implications of hypogammaglobulinemia in patients with chronic lymphocytic leukemia and lymphocytic lymphosarcoma.Ann Intern Med.1959; 51: 501–516.
39.
MorrisonV.A.. The infectious complications of chronic lymphocytic leukemia.Semin Oncol.1998; 25: 98–106.
40.
FoaR., CatovskyD., LauriaF.. Reduced T-colony forming capacity by T-lymphocytes from B-chronic lymphocyte leukaemia.Br J Haematol.1980; 46: 623–625.
41.
PlatsoucasC.D., FernandesG., GuptaS.L.. Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon.J Immunol.1980; 125: 1216–1223.
42.
ChapelH.M., BunchC.. Mechanisms of infection in chronic lymphocytic leukemia.Semin Hematol.1987; 24: 291–296.
43.
VarsanoI., SchonfeldT.M., MatothY.. Severe disseminated adenovirus infection successfully treated with a thymic humoral factor, THF.Acta Paediatr Scand.1977; 66: 329–331.
44.
DaganR., SchwartzR.H., InselR.A.. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody.Pediatr Infect Dis.1984; 3: 246–251.
45.
HallC.B.. Ribavirin: beginning the blitz on respiratory viruses?Pediatr Infect Dis.1985; 4: 668–671.
46.
CassanoW.F.. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation.Bone Marrow Transplant.1991; 7: 247–248.